CVS Health (NYSE: CVS) is a big name in healthcare, and it has generally been seen as a good way to invest in the industry.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, has posted a ...

A bill that aims to increase pharmacy benefit managers’ transparency by requiring them to report data to the agency that ...

The last reform would be increasing transparency around the PBM business model, such as the rebates they collect and their markup practices, since it is "largely opaque" to employers and other ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

The National Community Pharmacists Association has joined a class action lawsuit against GoodRx, as well as CVS Caremark, ...